Galapagos Starts Trial of Therapy It Hopes Becomes Part of Triple-Combination CF Treatment
Cystic Fibrosis, News
Galapagos has started a Phase 1 clinical trial of its novel potentiator GLPG3067 for cystic fibrosis (CF). It is the second Phase 1 trial the company is conducting. The other one ... Read more